André R. Arellano
André R. Arellano publishes mostly in Cardiology and Cardiovascular Medicine, Hematology and Genetics, on topics such as Blood Coagulation and Thrombosis Mechanisms, Venous Thromboembolism Diagnosis and Management and Genetic Associations and Epidemiology.
- World rank
- #1,391,501 of 7,710,434 ranked researchers
- Rank in United States
- #439,759 of 1,627,098
- Works
- 58
- Citations
- 1.6k
- Citations per work
- 27.6
What does André R. Arellano research?
André R. Arellano's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3153.1%
- Health Sciences1932.6%
- Medicine1932.6%
- Life Sciences814.3%
- 1Cardiology and Cardiovascular Medicine11% of their works
- 2Hematology10% of their works
- 3Genetics8% of their works
- 4Molecular Biology7% of their works
- 5Surgery7% of their works
- 6Internal Medicine5% of their works
Research topics
- Blood Coagulation and Thrombosis Mechanisms
- Venous Thromboembolism Diagnosis and Management
- Genetic Associations and Epidemiology
- Health Systems, Economic Evaluations, Quality of Life
- Lipoproteins and Cardiovascular Health
- Mobile Health and mHealth Applications
- Atrial Fibrillation Management and Outcomes
- Diabetes, Cardiovascular Risks, and Lipoproteins
Which keywords describe André R. Arellano's research?
The keywords of their largest research topics: Antithrombotic Therapy, Protease-Activated Receptors, Thrombin, Pulmonary Embolism, Venous Thromboembolism, Genetic Variation, Genome-Wide Association and Cost-effectiveness Analysis.
- Mobile Health
- Cardiovascular Disease
- Anticoagulant Therapy
- Cholesterol-lowering
- Cost-effectiveness Analysis
- Genetic Variation
- Pulmonary Embolism
- Protease-Activated Receptors
- Antithrombotic Therapy
- Thrombin
- Venous Thromboembolism
- Genome-Wide Association
- Quality of Life
- Statins
- Atrial Fibrillation
- Metabolic Syndrome
- mHealth
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Antithrombotic Therapy192 topics
- Protease-Activated Receptors111 topic
- Thrombin111 topic
- Pulmonary Embolism81 topic
- Venous Thromboembolism81 topic
- Genetic Variation61 topic
- Genome-Wide Association61 topic
- Cost-effectiveness Analysis51 topic
- Quality of Life51 topic
- Cholesterol-lowering41 topic
- Statins41 topic
- Anticoagulant Therapy31 topic
- Atrial Fibrillation31 topic
- Cardiovascular Disease31 topic
- Metabolic Syndrome31 topic
- Mobile Health31 topic
- mHealth31 topic
Where does André R. Arellano work?
André R. Arellano's main affiliation in the publication record is Quest Diagnostics (United States), United States.
How many publications and citations does André R. Arellano have?
OpenAlex counts 58 works and 1,600 citations for André R. Arellano, an h-index of 18, ranking #1,391,501 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about André R. Arellano. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.